Exelon Patch and Combination With Memantine Comparative Trial

NCT01025466 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

206

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Rivastigmine transdermal patch (Exelon patch), memantine
DRUG: Rivastigmine transdermal patch

Sponsor

Inha University Hospital